Hemostasis and ageing
Tóm tắt
On March 19, 2008 a Symposium on Pathophysiology of Ageing and Age-Related Diseases was held in Palermo, Italy. The lecture of D. Mari on Hemostasis and ageing is summarized herein. Physiological ageing is associated with increased plasma levels of many proteins of blood coagulation together with fibrinolysis impairment. This may be of great concern in view of the known association between vascular and thromboembolic diseases and ageing. On the other hand, centenarians are characterized by a state of hypercoagulability and possession of several high-risk alleles and well-known atherothrombotic risk markers but this appears to be compatible with longevity and/or health. Parameters considered risk factors for atherosclerotic vascular diseases in young people may lose their biological significance in advanced age and assume a different role.
Tài liệu tham khảo
Mari D, Coppola R, Provenzano R: Hemostasis factors and aging. Exp Gerontol. 2008, 43: 66-73. 10.1016/j.exger.2007.06.014.
Meade TW, North WRS, Chakrabarti R, Haines AP, Stirling Y: Population-based distributions of haemostatic variables. Br Med Bull. 1977, 33: 283-288.
Ershler WB: Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993, 41: 176-181.
Balleisen L, Bailey J, Epping PH, Schulte H, Loo van De J: Epidemiological study on factor VII, factor VIII and fibrinogen in industrial population. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill using and menopause. Thromb Haemost. 1985, 54: 475-479.
Bauer KA, Kass BL, Cate HC, Hawiger JJ, Rosenberg RD: Factor IX is activated in vivo by the tissue factor mechanism. Blood. 1990, 76: 731-736.
Ariens R, Coppola R, Potenza I, Mannucci P: The increase with age of the components of the tissue factor coagulation pathway is gender-dependent. Blood Coagul Fibrinolysis. 1995, 6: 433-437. 10.1097/00001721-199507000-00010.
Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H: Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997, 97: 775-784. 10.1046/j.1365-2141.1997.1222936.x.
Reiner AP, Carty CL, Jenny NS, Nievergelt C, Cushman M, Stearns-Kurosawa DJ, Shinichiro Kurosawa S, Kuller LH, Lange LA: PROC, PROCR, and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study. J Thromb Haemost. 2008, 6 (10): 1625-1632. 10.1111/j.1538-7836.2008.03118.x.
Aihara K, Takamori N, Kanawaga Y, Akaike M, Fujimura M, Yoshida T, Kato M, Yamaguchi H, Kato S, Ikeda Y, Arase T, Kondo A, Matsumoto T: Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals. Circulation. 2004, 109: 2761-5. 10.1161/01.CIR.0000129968.46095.F3.
Mari D, Duca F, Mannucci PM, Franceschi C: Mutant factor V [Arg506Gln] in healthy centenarians. Lancet. 1996, 347: 1044-10.1016/S0140-6736(96)90181-6.
Rees DC, Liu YT, Cox MJ, Elliott P, Wainscoat JS: Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age. Thromb Haemost. 1997, 78: 1357-1359.
Kristensen SR, Andersen-Ranberg K, Bathum L, Jeune B: Factor V Leiden and venous thrombosis in Danish centenarians. Thromb Haemost. 1998, 80: 860-861.
Heijmans BT, Westendorp RG, Knook DL: Risk of mortality and the factor V Leiden mutation in a population-based cohort. Thromb Haemost. 1998, 80: 607-609.
Abbate R, Prisco D, Rostagno C, Boddi M, Gensini GF: Age-related changes in the haemostatic system. Int J Clin Lab Res. 1993, 23: 1-3. 10.1007/BF02592271.
Rizzo MR, Ragno E, Barbieri M, De Lucia D, Manzella D, Tagliamonte MR, Colaizzo D, Margaglione M, Paolisso G: Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians. Atherosclerosis. 2002, 160: 385-390. 10.1016/S0021-9150(01)00575-5.
Reiner AP, Diehr P, Browner WS, Humphries SE, Jenny NS, Cushman M, Tracy RP, Walston J, Lumley T, Newman AB, Kuller LH, Psaty B: Common Promoter Polymorphisms of Inflammation and Thrombosis Genes and Longevity in Older Adults: The Cardiovascular Health Study. Atherosclerosis. 2005, 181: 175-83. 10.1016/j.atherosclerosis.2005.01.028.
Bajzar L, Jain N, Wang P, Walker JB: Thrombin Activatable Fibrinolysis Inhibitor: not just an Inhibitor of Fibrinolysis. Crit Care Med. 2004, 2: S320-4. 10.1097/01.CCM.0000126361.00450.B1.
Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD: Hypercoagulability in centenarians: The paradox of successful aging. Blood. 1995, 85: 3144-3149.
Coppola R, Mari D, Lattuada A, Franceschi C: Von Willebrand factor in Italian centenarians. Haematologica. 2003, 88: 39-43.
Meroni PL, Mari D, Monti D, Coppola R, Capri M, Salvioli S, Tincani A, Gerli R, Franceschi C: Anti-beta 2 glycoprotein I antibodies in centenarians. Exp Gerontol. 2004, 39: 1459-1465. 10.1016/j.exger.2004.08.003.
Mannucci PM, Mari D, Merati G, Tagliabue L, Sacchi E, Taioli E, Sansoni P, Bertolini S, Franceschi C: Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians. Arterioscler Thromb Vasc Biol. 1997, 17 (4): 755-759.
Sacchi E, Duca F, Franceschi C, Mari D: Prothrombin Gene Mutation [G20210A] in Healthy Centenarians. Thromb Haemost. 1999, 81: 990-991.
Weverling-Rijnsburger AW, Blauw GJ, Lagaay A, Knook DL, Meinders AE, Westendorp RG: Total cholesterol and risk of mortality in the oldest old. Lancet. 1997, 350: 1119-1123. 10.1016/S0140-6736(97)04430-9.
Candore G, Balistreri CR, Grimaldi MP, Listì F, Vasto S, Caruso M, Caimi G, Hoffmann E, Colonna-Romano G, Lio D, Paolisso G, Franceschi C, Caruso C: Opposite role of pro-inflammatory alleles in acute myocardial infarction and longevity: results of studies performed in a Sicilian population. Ann N Y Acad Sci. 2006, 1067: 270-275. 10.1196/annals.1354.035.